13G Filing: Brookside Capital and Immune Design Corp. (IMDZ)

Page 4 of 7 – SEC Filing

(b)
Address of the Principal Office or, if none, residence
The principal business address of each of the Trading Fund, Brookside
Investors II and BCPE Management is c/o Bain Capital Public Equity, LP,
200 Clarendon Street, Boston, MA 02116.(c)
Citizenship
Each of the Trading Fund, Brookside Investors II and BCPE Management
is organized under the laws of the State of
Delaware.(d)
Title of Class of Securities
The class of equity securities of the Company to which this filing on
Schedule 13G relates is Common Stock
(“Common Stock”).(e)
CUSIP Number
The CUSIP number of the Company’s Common Stock is 45252L103.

Item 3. If this statement is filed pursuant to 240.13d-1(b) or
240.13d-2(b) or (c), check whether the person filing is a:

(a)
?
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).(b)
?
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).(c)
?
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).(d)
?
Investment company registered under section 8 of the Investment Company
Act of 1940 (15 U.S.C. 80a-8).

Follow Immune Design Corp. (NASDAQ:IMDZ)